Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (46)	7/13/1999 3:04:00 PM
From: Impristine-2	Read Replies (1) \| Respond to of 2557

Richard that's really nice. Garlic and Onions Work too. Kind of gets the Phlegm going. UgghHHkkUMMmm... Hey! ~90 Percent of headaches are myofascial based! Wow! Do you have a headache! Yes! No! What kind of reliability is that! I change my head position. Presto! No more headache! if it's myofascial based. that is! Hey! by the Way! GOD BLESS AMERICA!

To: scaram(o)uche who wrote (46)	7/13/1999 3:51:00 PM
From: Rudy Saucillo	Read Replies (1) \| Respond to of 2557

Excellent comments, Rick. Should be an exciting 6 months. We should see results from the final 2 PhIII studies over the next couple of months followed in Q4 with the pleconaril NDA for viral meningitis. Given the strength of the PhII and PhIII data we've seen to date, there's no reason, IMO, to believe the remaining results should be out of line. BTW, the data from the compassionate use program also has been outstanding (that is, the limited data that's been released). Although VPHM won't be able advertise this, I would anticipate a fair amount of off-label use once pleconaril is approved. Regarding price, I really like Rick's target! :-) Seriously, I see no reason why we shouldn't blow through our 52 wk high of 24 sooner rather than later! Rudy